靈氣作為一個疼痛管理輔助篩查結腸鏡檢查。

Reiki as a pain management adjunct in screening colonoscopy. 靈氣作為一個疼痛管理輔助篩查結腸鏡檢查。 
Gastroenterol Nurs. 2012 Sep;35(5):308-12. Reiki as a pain management adjunct in screening colonoscopy. Bourque AL1 , Sullivan ME, Winter MR. Author information 1 Boston Medical Center, Boston, Massachusetts 02118, USA. alda.bourque@bmc.org 

Abstract The purpose of this study was to determine whether the use of Reiki decreases the amount of meperidine administered to patients undergoing screening colonoscopy. The literature review reveals limited studies to show whether Reiki has been able to decrease the amount of opioid the patient receives during screening colonoscopy. A chart review of 300 patients was conducted to obtain baseline average doses of meperidine patients received as the control. Following the chart review, 30 patients were recruited to the Reiki study. Twenty-five of the study arm patients received Reiki in conjunction with meperidine. Five randomly chosen study arm patients received placebo Reiki in conjunction with meperidine in an attempt to blind the clinicians to the treatment received by the patients.

Results showed that there were no significant differences in meperidine administration between the patients in the chart review group (control) and the Reiki group. The study revealed that 16% who received Reiki, together with intravenous administration of conscious sedation, received less than 50 mg of meperidine. All the patients in the chart review group received more than 50 mg of meperidine. Results from this pilot study suggest that there may be a decrease in meperidine needed during screening colonoscopy when patients receive Reiki treatments before the procedure. A larger study powered to detect smaller medication differences is the next step in more accurately determining the effect of Reiki on pain management. Gastroenterol 護士。

作者信息 波士頓醫療中心,波士頓,馬薩諸塞州 02118,美國。alda.bourque@bmc.org 抽象 這項研究的目的是確定使用靈氣是否減少哌替啶的數量管理的患者進行篩查結腸鏡檢查。文獻綜述揭示了有限的 研究,以顯示靈氣是否能夠減少患者在篩查結腸鏡時接受的阿片類藥物的量。對 300 名患者的圖表進行評估, 以獲得作為對照的哌替啶患者的基線平均劑量。在圖表回顧之後,30 名患者被招募到靈氣研究。25 名研究組患 者接受了靈氣聯合哌替啶治療。5 名隨機選擇的研究組患者接受安慰劑靈氣聯合哌替啶治療,試圖使臨床醫生盲目接受患者的治療。結果顯示圖表審查組(對照組)和靈氣組患者的哌替啶給藥間無顯著差異。

該研究顯示,接 受靈氣治療的患者中,有 16%接受了清醒鎮靜的靜脈注射,接受了不足 50mg 的哌替啶治療。圖表綜述組中的 所有患者接受超過 50mg 的哌替啶。這項初步研究的結果表明,在手術前接受靈氣治療的患者在篩查結腸鏡時, 可能需要哌替啶降低。更大的研究能夠檢測到較小的用藥差異,是更準確地確定靈氣對疼痛管理的影響的下一步。 該研究顯示,接受靈氣治療的患者中,有 16%接受了清醒鎮靜的靜脈注射,接受了不足 50mg 的哌替啶治療。 圖表綜述組中的所有患者接受超過 50mg 的哌替啶。這項初步研究的結果表明,在手術前接受靈氣治療的患者在 篩查結腸鏡時,可能需要哌替啶降低。更大的研究能夠檢測到較小的用藥差異,是更準確地確定靈氣對疼痛管理 的影響的下一步。該研究顯示,接受靈氣治療的患者中,有 16%接受了清醒鎮靜的靜脈注射,接受了不足 50mg 的哌替啶治療。圖表綜述組中的所有患者接受超過 50mg 的哌替啶。這項初步研究的結果表明,在手術前接受靈 氣治療的患者在篩查結腸鏡時,可能需要哌替啶降低。更大的研究能夠檢測到較小的用藥差異,是更準確地確定 靈氣對疼痛管理的影響的下一步。這項初步研究的結果表明,在手術前接受靈氣治療的患者在篩查結腸鏡時,可 能需要哌替啶降低。更大的研究能夠檢測到較小的用藥差異,是更準確地確定靈氣對疼痛管理的影響的下一步。 這項初步研究的結果表明,在手術前接受靈氣治療的患者在篩查結腸鏡時,可能需要哌替啶降低。更大的研究能 夠檢測到較小的用藥差異,是更準確地確定靈氣對疼痛管理的影響的下一步。

謝再福
Comments